Assessment of cardiac performance with quantitative radionuclide angiocardiography. Effects of oral propranolol on global and regional left ventricular function in coronary artery disease.
暂无分享,去创建一个
R. Marshall | A. Gottschalk | H. Berger | L. Cohen | L. Reduto | B. Zaret
[1] B. Zaret,et al. Variability in sequential measures of left ventricular performance assessed with radionuclide angiocardiography. , 1978, The American journal of cardiology.
[2] R. Marshall,et al. Assessment of Cardiac Performance with Quantitative Radionuclide Angiocardiography: Sequential Left Ventricular Ejection Fraction, Normalized Left Ventricular Ejection Rate, and Regional Wall Motion , 1977, Circulation.
[3] M. Pagani,et al. Effects of propranolol on regional myocardial function, electrograms, and blood flow in conscious dogs with myocardial ischemia. , 1977, The Journal of clinical investigation.
[4] H. Gold,et al. Propranolol-induced reduction of signs of ischemic injury during acute myocardial infarction. , 1976, The American journal of cardiology.
[5] R. Shanks,et al. The Clinical Pharmacology of Beta Adrenergic Blocking Drugs , 1976, Journal of the Royal College of Physicians of London.
[6] S. Treves,et al. Quantitative radionuclide angiocardiography. Determination of left ventricular ejection fraction in children. , 1976, British heart journal.
[7] S. Vatner,et al. Effects of isoproterenol on regional myocardial function, electrogram, and blood flow in conscious dogs with myocardial ischemia. , 1976, The Journal of clinical investigation.
[8] J. Ross,et al. Regional Myocardial Function in the Conscious Dog During Acute Coronary Occlusion and Responses to Morphine, Propranolol, Nitroglycerin, and Lidocaine , 1976, Circulation.
[9] R Gorlin,et al. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. , 1976, The American journal of cardiology.
[10] M. Chatterjee,et al. Beta adrenergic blockade in hypertension. , 1976, The Journal of the Association of Physicians of India.
[11] M. LeWinter,et al. Effects of oral propranolol in normal subjects. , 1976, Clinical pharmacology and therapeutics.
[12] H. Schelbert,et al. Left Ventricular Performance Assessed by Radionuclide Angiocardiography and Echocardiography in Patients with Previous Myocardial Infarction , 1975, Circulation.
[13] C. Chidsey,et al. Correlation of Plasma Propranolol Concentration with Therapeutic Response in Patients with Angina Pectoris , 1975, Circulation.
[14] R. Dinsmore,et al. Left Ventricular Wall Motion Response to Intravenous Propranolol , 1975, Circulation.
[15] P. Kligfield,et al. Noninvasive assessment of clinical response to oral propranolol therapy. , 1975, The American journal of cardiology.
[16] H R Schelbert,et al. Nontraumatic determination of left ventricular ejection fraction by radionuclide angiocardiography. , 1975, Circulation.
[17] D. Harrison,et al. Effect of propranolol on left ventricular function, segmental wall motion, and diastolic pressure-volume relation in man. , 1975, British heart journal.
[18] D. Shand. Drug therapy: Propranolol. , 1975, The New England journal of medicine.
[19] P. Steele,et al. Measurement of left heart ejection fraction and end-diastolic volume by a computerized, scintigraphic technique using a wedged pulmonary arterial catheter. , 1974, The American journal of cardiology.
[20] S. Ayres,et al. Propranolol in the Treatment of Acute Myocardial Infarction: Effect on Myocardial Oxygenation and Hemodynamics , 1974, Circulation.
[21] D. Donald,et al. Circulation Research an Official Journal of the American Heart Association Brief Reviews Myocardial Performance after Excision of the Extrinsic Cardiac Nerves in the Dog , 2022 .
[22] D. Brutsaert,et al. Cardiac muscle mechanics in the evaluation of myocardial contractility and pump function: problems, concepts, and directions. , 1973, Progress in cardiovascular diseases.
[23] D. Greenblatt,et al. Adverse reactions to propranolol in hospitalized medical patients: a report from the Boston Collaborative Drug Surveillance Program. , 1973, American heart journal.
[24] H. Anger,et al. Cardiac evaluation from radioisotope dynamics. , 1972, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] R. Tarazi,et al. Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. , 1972, The American journal of cardiology.
[26] R. Helfant,et al. Abnormalities of Left Ventricular Contraction Induced by Beta Adrenergic Blockade , 1971, Circulation.
[27] J. Covell,et al. Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions , 1971, Circulation.
[28] J. Oates,et al. Plasma propranolol levels in adults With observations in four children , 1970, Clinical pharmacology and therapeutics.
[29] R. Gorlin,et al. Cardiovascular Pharmacology of Propranolol in Man , 1969, Circulation.
[30] J. W. Cox,et al. Hemodynamic Effects of Nitroglycerin, Propranolol, and Their Combination in Coronary Heart Disease , 1969, Circulation.
[31] J. Parker,et al. Hemodynamic effects of propranolol in coronary heart disease. , 1968, The American journal of cardiology.
[32] R. Bing,et al. A Comparative Study of Nitroglycerin and Propranolol , 1967, Circulation.
[33] E. Sonnenblick,et al. Cardiac Norepinephrine Stores and the Contractile State of Heart Muscle , 1966, Circulation research.
[34] J F Williams,et al. Effects of exercise on myocardial force-velocity relations in intact unanesthetized man: relative roles of changes in heart rate, sympathetic activity, and ventricular dimensions. , 1965, The Journal of clinical investigation.